Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 22, 2019

SELL
$5.69 - $11.28 $5,121 - $10,152
-900 Closed
0 $0
Q3 2018

Oct 26, 2018

BUY
$9.69 - $17.79 $8,711 - $15,993
899 Added 89900.0%
900 $9,000
Q3 2018

Oct 23, 2018

BUY
$9.69 - $17.79 $9 - $17
1 New
1 $9,000

Others Institutions Holding SPRO

About Spero Therapeutics, Inc.


  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $33.3M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track Farmers & Merchants Trust CO Of Chambersburg Pa Portfolio

Follow Farmers & Merchants Trust CO Of Chambersburg Pa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farmers & Merchants Trust CO Of Chambersburg Pa, based on Form 13F filings with the SEC.

News

Stay updated on Farmers & Merchants Trust CO Of Chambersburg Pa with notifications on news.